Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Colfax, Investors, Johnson & Johnson, Merck: U.S. Equity Preview

Sept. 9 (Bloomberg) -- Shares of the following companies may have unusual moves in U.S. trading on Sept. 12. Stock symbols are in parentheses.

Colfax Corp. (CFX US): Charter International Plc is close to accepting a bid from the Fulton, Maryland-based manufacturer of pumps and specialty valves, the Daily Telegraph reported, citing unnamed sources.

Investors Real Estate Trust (IRET US): The Minot, North Dakota-based real estate investment trust reported funds from operations in the first quarter were 16 cents a share, matching the average analyst estimate.

Johnson & Johnson (JNJ US): The world’s second-biggest maker of health-care products failed to win U.S. clearance for wider use of Simponi, a two-year-old arthritis drug.

Merck & Co. (MRK US): The second-largest U.S. drugmaker, Warner Chilcott Plc, Roche Holding AG and Novartis AG should add clarifications on the length of time that osteoporosis patients may take their bone drugs to reduce the risk of fractures, outside advisers to the Food and Drug Administration said.

To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net.

To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.